Namrata Patil

Namrata Patil

Company: Genentech

Job title: Principal Scientist


Examining How Anti-TIGIT Antibody Tiragolumab Leverages Myeloid Cells & Regulatory T-Cells to Improve PD-L1 Checkpoint Blockade 4:00 pm

• Biomarker data from early phase studies including a randomized phase 2 study • Preclinical confirmatory studies that shed light on the potential mechanisms of TIGIT blockadeRead more

day: Day One

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.